We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Akebia Therapeutics
AKBA
$343M
| $19.4K | 0.02% |
+10,590
| New | +$16.9K |
|
1102
FRP Holdings
FRPH
$449M
| $19.3K | 0.02% |
1,256
-914
| -42% | -$27.4K |
|
1103
Bristow Group
VTOL
$1.37B
| $19.2K | 0.02% |
707
-293
| -29% | -$7.81K |
|
1104
Palomar
PLMR
$3.65B
| $19.2K | 0.02% |
229
-2,541
| -92% | -$174K |
|
|
PWSC
1105
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $19.1K | 0.02% |
899
-3,626
| -80% | -$82.3K |
|
1106
MetLife
MET
$61.2B
| $19.1K | 0.02% |
258
-374
| -59% | -$26.1K |
|
1107
Korea Electric Power
KEP
$15.6B
| $19.1K | 0.02% |
+2,292
| New | +$18.5K |
|
1108
Tyson Foods
TSN
$21.6B
| $19.1K | 0.02% |
325
+20
| +7% | +$1.1K |
|
1109
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $19.1K | 0.02% |
488
+485
| +16,167% | +$19.1K |
|
1110
Ametek
AME
$55B
| $19K | 0.02% |
104
-361
| -78% | -$62.2K |
|
1111
First Commonwealth Financial
FCF
$2.13B
| $19K | 0.02% |
+1,363
| New | +$18.8K |
|
|
VRNA
1112
DELISTED
Verona Pharma
VRNA
| $18.9K | 0.02% |
+1,175
| New | +$20.3K |
|
|
WNS
1113
DELISTED
WNS Holdings
WNS
| $18.8K | 0.02% |
372
-827
| -69% | -$49.9K |
|
1114
Nutanix
NTNX
$15.5B
| $18.8K | 0.02% |
+304
| New | +$17.5K |
|
1115
Reliance Steel & Aluminium
RS
$20.7B
| $18.7K | 0.02% |
56
+41
| +273% | +$12.5K |
|
1116
West Pharmaceutical
WST
$23.1B
| $18.6K | 0.02% |
+47
| New | +$17.4K |
|
1117
Core & Main
CNM
$8.11B
| $18.5K | 0.02% |
324
-1,542
| -83% | -$70.6K |
|
1118
Synchrony
SYF
$24.3B
| $18.5K | 0.02% |
+430
| New | +$17.1K |
|
1119
ASE Group
ASX
$78B
| $18.4K | 0.02% |
1,678
-5,102
| -75% | -$50.1K |
|
1120
Universal Health Services
UHS
$9.75B
| $18.4K | 0.02% |
+101
| New | +$16.7K |
|
1121
SK Telecom
SKM
$13.6B
| $18.4K | 0.02% |
+853
| New | +$18.3K |
|
1122
Gogo Inc
GOGO
$533M
| $18.4K | 0.02% |
2,092
-22,416
| -91% | -$202K |
|
1123
First Financial Bankshares
FFIN
$4.96B
| $18.3K | 0.02% |
558
-1,960
| -78% | -$60.2K |
|
1124
PBF Energy
PBF
$7.29B
| $18.3K | 0.02% |
317
-512
| -62% | -$25.1K |
|
1125
Dentsply Sirona
XRAY
$2.63B
| $18.2K | 0.02% |
+549
| New | +$18.8K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.